Info
Metastatic castration sensitive prostate cancer
(mCSPC)
- Prostate CA that responds to lowering testosterone to castrate levels (<50 ng/dL)
- N1M0: RT + long-term neoadjuvant/concurrent/adjuvant ADT (2-3 y) or ADT alone
- M1: Evaluate if low volume or high volume